First human test: new Drug's safety under the microscope
NCT ID NCT06070857
Summary
This was a first-in-human study to check the safety and see how the body processes a new drug called LV232. It involved 81 healthy Chinese volunteers who received a single dose of either the drug or a placebo. The main goal was to see how safe the drug is and to measure its levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Xuhui Central Hospital
Shanghai, Shanghai Municipality, 201900, China
Conditions
Explore the condition pages connected to this study.